Hindustan Unilever Unveils ‘WINI’ Growth Strategy, Targets 22‑24% EBITDA Margin

⚡ Key Financial Takeaways

HUL introduces WINI strategy, moving from WIMI to focus on new India markets.

EBITDA margin guidance raised to 22‑24% (upper band) from 23.5% previously.

Growth will come 40% from premiumisation, 40% from user base expansion, 20% from innovations.

Competitive pressure remains high in Home Care and Toilet Soaps; Beauty & Wellbeing and Nutrition are growth drivers.

Projected sales CAGR 9% and PAT 8.8% for FY26‑28; target price ₹2,320 (45x FY28 EPS).

💡 Why It Matters

HUL’s strategic pivot to WINI signals a broader shift in India’s FMCG sector toward premium products and new market penetration. The updated EBITDA guidance and growth targets provide investors with clearer expectations for the company’s financial trajectory, while the emphasis on innovation and cost control addresses competitive pressures in key categories.

HUL’s New Growth Blueprint

At its recent analyst meeting, Hindustan Unilever (HUL) revealed a shift in its growth philosophy from *Winning in Many India’s* (WIMI) to *Winning in New India* (WINI). The company will now prioritise premiumisation, higher product usage and entry into high‑growth categories, signalling a more aggressive push into emerging consumer segments.

EBITDA Margin Outlook

HUL has revised its EBITDA margin guidance, setting the upper band at **22‑24 %** (up from a previously quoted 23.5 %). The company plans to leverage cost savings from sourcing, media efficiency and premium pricing to support this target.

Drivers of Growth

Management outlined a three‑pronged approach:

1. **Premiumisation & Consumption** – 40 % of the margin lift is expected from higher‑priced products and increased consumption. 2. **User Base Expansion** – Another 40 % will come from attracting new users, particularly in untapped markets. 3. **Innovation** – 20 % will be driven by new product launches and market‑making initiatives.

Competitive Landscape

While the Home Care and Toilet Soaps segments remain fiercely competitive, HUL’s initiatives in Beauty & Wellbeing and Nutrition are projected to cushion margin pressures. The company’s investment in capex, new innovations and market entry is aimed at sustaining long‑term profitability.

Financial Projections

Analysts forecast a **9 % CAGR in sales** and **8.8 % CAGR in PAT** through FY26‑28. HUL trades at **38.6× FY28 EPS**, the lowest multiple in a decade, yet still offers a 2 %+ dividend yield. The target price is set at **₹2,320** (45× FY28 EPS), reflecting a favourable risk‑reward profile.

Risks

Short‑term growth and margins could be impacted by higher inflation and El Niño‑induced supply disruptions. Nonetheless, the company’s focus on premiumisation and cost efficiency is expected to mitigate these headwinds over the long run.

🏛️ Background & Context

HUL, a subsidiary of Unilever, is one of India’s largest consumer goods companies. The company’s move to a volume‑led growth model aligns with industry trends where premiumisation and category expansion drive profitability. The revised margin guidance reflects the firm’s confidence in its cost‑saving initiatives and media efficiency.

The company’s focus on Beauty & Wellbeing and Nutrition comes at a time when Indian consumers are increasingly health‑conscious and willing to pay more for perceived quality.

El Niño events have historically disrupted supply chains in the FMCG sector, leading to higher input costs and potential margin compression.

The 2 %+ dividend yield offers a modest return for income‑seeking investors, while the target price of ₹2,320 positions HUL as an attractive long‑term holding.

👁️ What To Watch Next

Investors should monitor HUL’s execution of its WINI strategy, particularly the rollout of new high‑growth products and market‑making activities. Upcoming earnings releases will reveal whether the company can sustain the projected 22‑24 % EBITDA margin and whether inflationary pressures or El Niño effects materially impact short‑term performance.